Physician profile
Michael J Ahern
NPI 1689626418
$522.37
in general payments reported to CMS, 2019-2025
11 companies · $396 in 2025
The $396 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $126 · 2025: $396.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $522.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $156.62 | 2023-2025 | Breztri, Airsupra |
| Novo Nordisk INC | $129.54 | 2025 | Ozempic, Wegovy |
| Pfizer INC. | $57.05 | 2025 | |
| Astellas Pharma US INC | $36.50 | 2025 | Veozah |
| Glaxosmithkline, LLC. | $26.50 | 2025 | Trelegy Ellipta |
| Teva Pharmaceuticals USA, INC. | $22.67 | 2025 | Austedo Xr |
| Merck Sharp & Dohme LLC | $22.60 | 2025 | Capvaxive, Vaxneuvance, Gardasil 9 |
| Lilly USA, LLC | $20.55 | 2025 | Zepbound, Mounjaro |
| Bayer Healthcare Pharmaceuticals INC. | $18.69 | 2025 | |
| Baxter Healthcare | $17.55 | 2025 | Hillrom - Cardiac Ambulatory Monitor |
| Lnhc, INC | $14.10 | 2025 | Zelsuvmi |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Ahern listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.